Adverse effects of drugs on the esophagus

Best Practice and Research: Clinical Gastroenterology

Volumn 24, Issue 2, 2010, Pages 91-97

  Tutuian, Radu ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Esophageal dysmotility; Lower esophageal sphincter; Medication induced reflux; Pill esophagitis

Indexed keywords

ACETYLSALICYLIC ACID; ALENDRONIC ACID; AMIFOSTINE; AMINOPHYLLINE; ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ATROPINE; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOMIPRAMINE; DIAZEPAM; DOXYCYCLINE; GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; MESNA; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; PACLITAXEL; PALIFERMIN; PIRENZEPINE; PLACEBO; RAZOXANE; SPASMOLYTIC AGENT; THEOPHYLLINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ARTICLE; BARRETT ESOPHAGUS; BONE DISEASE; CLINICAL TRIAL; DOSE RESPONSE; DRUG ACTIVITY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG RETENTION; DRUG WITHDRAWAL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGITIS; ESOPHAGUS FUNCTION; ESOPHAGUS FUNCTION DISORDER; ESOPHAGUS HEMORRHAGE; ESOPHAGUS INJURY; ESOPHAGUS MOTILITY; ESOPHAGUS PERFORATION; ESOPHAGUS STRICTURE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; HYPERCALCEMIA; LOW DRUG DOSE; LOWER ESOPHAGUS SPHINCTER PRESSURE; MALARIA; MUCOSA INFLAMMATION; PATHOGENESIS; POSTMARKETING SURVEILLANCE; POSTMENOPAUSE OSTEOPOROSIS; REFLUX ESOPHAGITIS; SIDE EFFECT; SKIN INFECTION; SYMPTOM;

DRUG THERAPY; ESOPHAGEAL DISEASES; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; HUMANS; MUCOUS MEMBRANE; RISK ASSESSMENT;

EID: 77749310339     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2010.02.005     Document Type: Article

References (25)

1. DeVault K.R. Presbyesophagus: a reappraisal. Curr Gastroenterol Rep 4 (2002) 193-199
2. Dent J., Dodds W.J., Friedman R.H., Sekiguchi T., Hogan W.J., Arndorfer R.C., et al. Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects. J Clin Invest 65 (1980) 256-267
3. Jaspersen D. Drug-induced oesophageal disorders: pathogenesis, incidence, prevention and management. Drug Saf 22 (2000) 237-249
4. Morris T.J., and Davis T.P. Doxycycline-induced esophageal ulceration in the U.S. Military service. Mil Med 165 (2000) 316-319
5. Kadayifci A., Gulsen M.T., Koruk M., and Savas M.C. Doxycycline-induced pill esophagitis. Dis Esophagus 17 (2004) 168-171
6. Vãlean S., Petrescu M., Cãtinean A., Chira R., and Mircea P.A. Pill esophagitis. Rom J Gastroenterol 14 (2005) 159-163
7. de Groen P.C., Lubbe D.F., Hirsch L.J., Daifotis A., Stephenson W., Freedholm D., et al. Esophagitis associated with the use of alendronate. N Engl J Med 335 (1996) 1016-1021
8. González-Martín A.J., Calvo E., Bover I., Rubio M.J., Arcusa A., Casado A., et al. Randomized phase II trial of carboplatin versus paclitaxel and carboplatin in platinum-sensitive recurrent advanced ovarian carcinoma: a GEICO (Grupo Espanol de Investigacion en Cancer de Ovario) study. Ann Oncol 16 (2005) 749-755
9. McDonnell A.M., and Lenz K.L. Palifermin: role in the prevention of chemotherapy- and radiation-induced mucositis. Ann Pharmacother 41 (2007) 86-94
10. Pearlman M., Jendiroba D., Pagliaro L., Keyhani A., Liu B., Freireich E.J., et al. Dexrazoxane's protection of jejunal crypt cells in the jejunum of C3Hf/Kam mice from doxorubicin-induced toxicity. Cancer Chemother Pharmacol 52 (2003) 477-481
11. Law A., Kennedy T., Pellitteri P., Wood C., Christie D., and Yumen O. Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 69 (2007) 1361-1368
12. Ypsilantis P., Tentes I., Assimakopoulos S.F., Kortsaris A., Scopa C.D., and Simopoulos C. Mesna ameliorates intestinal mucosa damage after ifosfamide administration in the rabbit at a dose-related manner. J Surg Res 121 (2004) 84-91
13. Hensley M.L., Hagerty K.L., Kewalramani T., Green D.M., Meropol N.J., Wasserman T.H., et al. American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants. J Clin Oncol 27 (2009) 127-145
14. Yamaoka K., Takenawa H., Tajiri K., Yamane M., Kadowaki K., Marumo F., et al. A case of esophageal perforation due to a pill-induced ulcer successfully treated with conservative measures. Am J Gastroenterol 91 (1996) 1044-1045
15. Zografos G.N., Georgiadou D., Thomas D., Kaltsas G., and Digalakis M. Drug-induced esophagitis. Dis Esophagus (2009 Apr 15) [Epub ahead of print]
16. Tahan V., Sayrak H., Bayar N., Erer B., Tahan G., and Dane F. Doxycycline-induced ulceration mimicking esophageal cancer. Cases J 1 (2008) 144
17. Stacher G., Schneider C., Steinringer H., Holzäpfel A., Gaupmann G., and Stacher-Janotta G. Effects of 3-days' intake of a sustained-release preparation of the nitric oxide donor, isosorbide dinitrate, on oesophageal motility. Aliment Pharmacol Ther 11 (1997) 967-971
18. Aggestrup S., and Jensen S.L. Effects of pirenzepine and atropine on basal lower esophageal pressure and gastric acid secretion in man: a placebo-controlled randomized study. Dig Dis 9 (1991) 360-364
19. Corley D.A., Levin T.R., Habel L.A., and Buffler P.A. Barrett's esophagus and medications that relax the lower esophageal sphincter. Am J Gastroenterol 101 (2006) 937-944
20. van Soest E.M., Dieleman J.P., Siersema P.D., Schoof L., Sturkenboom M.C., and Kuipers E.J. Tricyclic antidepressants and the risk of reflux esophagitis. Am J Gastroenterol 102 (2007) 1870-1877
21. Lagergren J., Bergström R., Adami H.O., and Nyrén O. Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med 133 (2000) 165-175
22. Tutuian R., and Castell D.O. Esophageal motility disorders (distal esophageal spasm, nutcracker esophagus, and hypertensive lower esophageal sphincter): modern management. Curr Treat Options Gastroenterol 9 (2006) 283-294
23. Kim H.S., Conklin J.L., and Park H. The effect of sildenafil on segmental oesophageal motility and gastro-oesophageal reflux. Aliment Pharmacol Ther 24 (2006) 1029-1036
24. Broekaert D., Fischler B., Sifrim D., Janssens J., and Tack J. Influence of citalopram, a selective serotonin reuptake inhibitor, on oesophageal hypersensitivity: a double-blind, placebo-controlled study. Aliment Pharmacol Ther 23 (2006) 365-370
25. Peghini P.L., Katz P.O., and Castell D.O. Imipramine decreases oesophageal pain perception in human male volunteers. Gut 42 (1998) 807-813